Singapore’s Agency for Science, Technology and Research (A*STAR) is working with Japan’s Chugai Group to come up with a therapeutic antibody to treat those with COVID-19. Professor Sir David Lane, A*STAR chief scientist and chairman of Chugai Pharmabody Research, explained the role of antibodies in treating COVID-19 infections.
Subscribe to our channel here: https://cna.asia/youtubesub
Subscribe to our news service on Telegram: https://cna.asia/telegram
CNA Lifestyle: http://www.cnalifestyle.com